Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)

SHE:300122 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,498	2,700	6,341	2,622	4,308	1,437
Cash & Short-Term Investments	2,498	2,700	6,341	2,622	4,308	1,437
Cash Growth	-23.48%	-57.41%	141.81%	-39.13%	199.68%	24.98%
Accounts Receivable	12,814	16,273	27,059	20,614	12,868	6,624
Other Receivables	475.8	10.95	7.8	8.39	6.87	9.07
Receivables	13,290	16,284	27,066	20,622	12,874	6,633
Inventory	20,246	22,218	8,986	8,020	7,385	3,406
Prepaid Expenses	50.02	8.11	9.73	-	0.59	5.04
Other Current Assets	29.75	82.61	111.37	148.53	185.63	55.67
Total Current Assets	36,113	41,293	42,514	31,413	24,754	11,537
Property, Plant & Equipment	5,975	5,371	5,120	4,693	3,557	2,387
Long-Term Investments	291	295	295	284.5	239	170
Goodwill	19.28	19.28	19.28	19.28	19.28	19.28
Other Intangible Assets	639.79	300.26	317.68	352.71	342.8	270.53
Long-Term Deferred Tax Assets	1,246	928.5	569.19	186.08	115.34	124.16
Long-Term Deferred Charges	1,932	1,514	1,088	731.97	485.04	402.79
Other Long-Term Assets	176.09	188.44	308.42	322.5	534.91	304.82
Total Assets	46,392	49,910	50,232	38,004	30,047	15,215
Accounts Payable	1,508	5,420	13,142	9,807	9,178	3,084
Accrued Expenses	51.85	866.78	1,673	1,240	1,090	501.54
Short-Term Debt	10,318	11,902	2,635	1,785	568.86	2,874
Current Portion of Long-Term Debt	175.41	83.83	36.41	-	-	-
Current Portion of Leases	-	9.81	10.2	9.81	0.25	-
Current Income Taxes Payable	168.48	80.33	434.59	347.7	933.25	323.7
Current Unearned Revenue	30.72	11.87	11.31	-	-	-
Other Current Liabilities	632.49	67.03	143.86	40.17	99.62	32.88
Total Current Liabilities	12,885	18,441	18,086	13,230	11,871	6,817
Long-Term Debt	3,594	347.59	328.08	210.64	236.41	-
Long-Term Leases	10.89	15.45	25.31	27.76	12.24	-
Long-Term Unearned Revenue	256.34	230.4	228.27	238.34	222.2	115.84
Long-Term Deferred Tax Liabilities	39.79	44.31	57.96	60.77	48.34	29.88
Other Long-Term Liabilities	-	-	-	-	-	4.35
Total Liabilities	16,786	19,079	18,726	13,768	12,390	6,967
Common Stock	2,394	2,394	2,400	1,600	1,600	1,600
Additional Paid-In Capital	210.19	-	47.96	207.96	207.96	207.96
Retained Earnings	26,727	28,437	29,058	22,428	15,849	6,441
Shareholders' Equity	29,607	30,831	31,506	24,236	17,657	8,249
Total Liabilities & Equity	46,392	49,910	50,232	38,004	30,047	15,215
Total Debt	14,098	12,359	3,035	2,033	817.76	2,874
Net Cash (Debt)	-11,600	-9,658	3,305	588.94	3,490	-1,437
Net Cash Growth	-	-	461.19%	-83.13%	-	-
Net Cash Per Share	-4.84	-4.03	1.38	0.25	1.45	-0.60
Filing Date Shares Outstanding	2,394	2,394	2,400	2,400	2,400	2,400
Total Common Shares Outstanding	2,394	2,394	2,400	2,400	2,400	2,400
Working Capital	23,228	22,852	24,428	18,183	12,883	4,720
Book Value Per Share	12.25	12.88	13.13	10.10	7.36	3.44
Tangible Book Value	28,672	30,511	31,169	23,864	17,295	7,959
Tangible Book Value Per Share	11.98	12.75	12.99	9.94	7.21	3.32
Buildings	-	2,634	2,522	1,705	1,042	1,014
Machinery	-	3,327	2,526	2,064	1,369	904.94
Construction In Progress	-	1,006	1,287	1,836	1,825	906.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.